Travere Therapeutics (TVTX) Q4 2023 Earnings

15FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.18
-0.03
1.12
2.27

Details

Expected EPS
-1.157636
Actual EPS
-1.18
Surprise EPS
-0.02
Surprise Percent
+1.93%

Description

Travere Therapeutics (TVTX) has reported earnings of -1.18 per share for Q4 2023.

0 Comments

Share your thoughts